1. Home
  2. KPTI vs FAT Comparison

KPTI vs FAT Comparison

Compare KPTI & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • FAT
  • Stock Information
  • Founded
  • KPTI 2008
  • FAT 2017
  • Country
  • KPTI United States
  • FAT United States
  • Employees
  • KPTI N/A
  • FAT N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • KPTI Health Care
  • FAT Consumer Discretionary
  • Exchange
  • KPTI Nasdaq
  • FAT Nasdaq
  • Market Cap
  • KPTI 44.5M
  • FAT 44.0M
  • IPO Year
  • KPTI 2013
  • FAT 2017
  • Fundamental
  • Price
  • KPTI $4.35
  • FAT $2.45
  • Analyst Decision
  • KPTI Buy
  • FAT Strong Buy
  • Analyst Count
  • KPTI 7
  • FAT 1
  • Target Price
  • KPTI $48.50
  • FAT $10.00
  • AVG Volume (30 Days)
  • KPTI 225.6K
  • FAT 40.9K
  • Earning Date
  • KPTI 08-05-2025
  • FAT 08-08-2025
  • Dividend Yield
  • KPTI N/A
  • FAT 11.43%
  • EPS Growth
  • KPTI N/A
  • FAT N/A
  • EPS
  • KPTI N/A
  • FAT N/A
  • Revenue
  • KPTI $142,126,000.00
  • FAT $582,704,000.00
  • Revenue This Year
  • KPTI $2.09
  • FAT N/A
  • Revenue Next Year
  • KPTI $12.90
  • FAT $8.68
  • P/E Ratio
  • KPTI N/A
  • FAT N/A
  • Revenue Growth
  • KPTI 1.19
  • FAT 10.63
  • 52 Week Low
  • KPTI $3.51
  • FAT $2.01
  • 52 Week High
  • KPTI $16.95
  • FAT $4.10
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 48.87
  • FAT 51.35
  • Support Level
  • KPTI $3.84
  • FAT $2.30
  • Resistance Level
  • KPTI $4.91
  • FAT $2.50
  • Average True Range (ATR)
  • KPTI 0.48
  • FAT 0.11
  • MACD
  • KPTI 0.02
  • FAT 0.01
  • Stochastic Oscillator
  • KPTI 45.25
  • FAT 50.00

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: